CLRYX
Price
$23.68
Change
+$0.22 (+0.94%)
Updated
Jul 31 closing price
Net Assets
1.28B
GFACX
Price
$70.77
Change
+$0.82 (+1.17%)
Updated
Jul 31 closing price
Net Assets
356.86B
Interact to see
Advertisement

CLRYX vs GFACX

CLRYX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
CLRYX vs. GFACX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLRYX is a Buy and GFACX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 357B vs. CLRYX (1.28B). CLRYX (0.00) and GFACX (0.00) have matching dividends . CLRYX was incepted earlier than GFACX: CLRYX (9 years) vs GFACX (25 years). GFACX (1.35) is less costly to investors than CLRYX (0.77). CLRYX is a more actively managed with annual turnover of: 53.00 vs. GFACX (32.00). GFACX has a lower initial minimum investment than CLRYX: GFACX (250) vs CLRYX (1000000). CLRYX annual gain was more profitable for investors over the last year : 6.81 vs. GFACX (-0.98). GFACX return over 5 years is better than : 3.92 vs. CLRYX (-13.58).
CLRYXGFACXCLRYX / GFACX
Total Expense Ratio0.661.3549%
Annual Report Gross Expense Ratio0.771.3557%
Fund Existence9 years25 years-
Gain YTD2.6445.15651%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.28B357B0%
Annual Yield % from dividends0.000.00-
Returns for 1 year6.81-0.98-695%
Returns for 3 years46.9027.74169%
Returns for 5 years-13.583.92-346%
Returns for 10 yearsN/A76.09-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
LSCGX20.360.21
+1.04%
Loomis Sayles Global Growth C
TBDAX21.930.22
+1.01%
PGIM Jennison Diversified Growth A
EPLMX25.79N/A
N/A
NYLI Epoch U.S. Equity Yield SIMPLE Cl
VWIAX62.69-0.08
-0.13%
Vanguard Wellesley® Income Admiral™
GSUKX25.96-0.06
-0.23%
Goldman Sachs International Eq Inc R6